Batches of six different medicines have been pulled off the shelves in Abu Dhabi for failing to meet official specifications.
They include Amydramine paediatric syrup, Moxal Plus tablet, Julphamox 500 mg capsule, Julmentin 2X tablet, Rosuvastatin and Oxaliplatin.
These drugs are prescribed for the treatment of allergies, colon cancer, respiratory tract infections and lowering cholesterol.
The Department of Health (DoH) Abu Dhabi has asked pharmacies and hospitals to return their stock to the supplier.

UAE, Arab states condemn US ambassador remarks on Israel
UAE, Belgium hold third round of political consultations in Abu Dhabi
AED 100 million boost for Mother of Nation Endowment for Orphans
UAE, Bahrain coordinate 100‑tonne Gaza aid shipment
